Demand for Quality Medical Diagnostics and Therapeutic Tools Drives the World Biophotonics Market, According to New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on Biophotonics markets. The global market for Biophotonics is forecast to exceed US$99 billion by the year 2018, driven by the rapidly aging population as well as the growing demand for quality healthcare across the world. Biophotonics proffers tremendous scope for designing a new range of cost-effective medical diagnostic and therapeutic tools that facilitate faster detection and optimum treatment of critical illnesses. Biophotonic applications in the field of microscopy, cytometry, and mass spectroscopy are expected to gain traction over traditional diagnostic techniques.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Biophotonics: A Global Strategic Business Report

San Jose, California (PRWEB) July 05, 2012

Follow us on LinkedIn – Biophotonics is one of the leading applications for instrumentation and measurement of lasers. The industry is striving to find applicability of the technology in rapidly and non-invasively identifying genome and protein structures. Biophotonic applications in the field of microscopy, cytometry, and mass spectroscopy are gradually beginning to exhibit benefits over traditional techniques in terms of cost, accuracy, and speed. The flexibility and the range of functionality is firmly positioning biophotonics as a disruptive technology with the capability of becoming the basis for conventional measuring application in life sciences research, discovery and development of pharmaceuticals, aquaculture, agriculture, and food sciences. Each year, malaria claims the lives of millions of children in third world countries, in spite of fervent efforts to contain and eliminate the disease. Despite the advances in medical science, tuberculosis, AIDS and other life-threatening illnesses also continue to persist well into the 21st century. The complexity of devising therapies for these illnesses lies in the tracing the root cause of the disease. Moreover, most of these diseases are diagnosed after the disease has progressed to an advanced stage, where the scope for treatment significantly narrows.

In the search for answers, the scientific community is turning to newer technologies such as Biophotonics, a branch of medical science harnessing the power of light (photons) to detect, scan, manipulate and measure biological materials. Biophotonics proffers tremendous scope for designing a new range of cost-effective medical diagnostic and therapeutic tools that facilitate faster detection and optimum treatment of critical illnesses. Demographic aging as well as the growing demand for quality healthcare across the planet are expected to drive the market for biophotonics in the near term. Over the last few years, demand for semiconductor lasers for laser therapy applications witnessed an upsurge with applications expanding from aesthetic treatments to surgeries, skin cancer therapy, and pain-relief treatments. In the near future, bioimaging is expected to substitute biopsies and existing mechanical scanning equipment.

In recent times, Photodynamic Therapies have been widely accepted as an effective medium for palliative care and for treating cancer during early stages. Several cancer-detection technologies already make use of photonic and similar optical technologies such as the use of gold markers derived from nano-shells. Through the integration of imaging modalities, namely ultrasound, photoacoustic imaging, and optical coherence tomography, into a single 5 millimeter biophotonics device, researchers can now detect presence of ovarian cancer among high-risk women at early stages. In case of timely detection of debilitating conditions like heart diseases, biophotonics comes into the picture, aiding the development of advanced laser mass spectroscopy-based tests that can provide conclusive results within moments of the onset of a heart attack.

Presently focused on Microscopy and other associated technologies, biophotonics are used for detecting biological functions at cellular and sub-cellular levels. Additionally, new technologies are gradually emerging on the basis of electrophysiology and other probes for quantifying biological functionalities. Biophotonics is also beginning to play a vital role in the food sciences sector for ensuring food safety, where the technology is being deployed in infrared and mass spectroscopy to detect contaminants in foodstuffs. Biophotonics-based imaging technology is also finding increasing application in diverse fields of study including nano-biotech, cell biology, cell or animal GFP, and non-linear microscopy. Live cell imaging, involving the study of protein expression, protein-to-protein interactions and localization, as well as transgenics for channel photoactivation are some of the most vibrant end-use application segments.

The United States represents the single largest region for biophotonics technologies, capturing a sizeable chunk of the global market, as stated by the new market research report on Biophotonics. Asia-Pacific, powered by emerging markets of India and China is poised to grow at an impressive pace of over 23% through 2018. By end-use, Medical Applications market represents a major segment for biophotonics, primarily in the field of diagnostics and therapeutics. Developed regions of North America and Europe comprise the largest markets for biophotonics medical applications. Non-Medical applications of biophotonics are currently the subject of intense research and are expected to gain significant mileage over the ensuing years.

Key players profiled in the report include AdvanDx, Inc., Andor Technology Plc., Becton, Dickinson and Company, BioTek Instruments, Inc., BIOLASE Technology, Inc., Caliper Life Sciences, Inc., Carl Zeiss MicroImaging GmbH, Epi-Light Limited, HORIBA, Ltd., Lumenis Ltd., Ocean Optics, Inc., Olympus America, Inc., PerkinElmer, Inc., PicoQuant GmbH, Technolas Perfect Vision GmbH, Zecotek Photonics, Inc., Zenalux Biomedical, Inc., among others.

The research report titled “Biophotonics: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive market overview, current market trends, key growth drivers, end-use analysis, recent industry activity, and profiles of major/niche global market participants. The report provides annual revenue estimates and projections for the years 2010 through 2018 in value (US$) terms for geographic markets including, US, Canada, Japan, Europe, Asia-Pacific and Rest of World. Key end-use applications analyzed include Medical (Therapeutics, Diagnostics and Others) and Non-Medical. The study also provides historic data for an insight into market evolution over the period 2004 through 2009.

For more details about this comprehensive market research report, please visit –
http://www.strategyr.com/Biophotonics_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

###


Contact

Attachments